ANRO Operating Cash Flow (Statement)
Alto Neuroscience, Inc. Common Stock · Operating Cash Flow (Statement)
ANRO Operating Cash Flow (Statement)
Latest reported-$19.76Mperiod ending
ANRO Quarterly Cash from Operations (-$6.02M → -$19.76M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
ANRO operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -19,760,000 | |
| -27,091,000 | |
| -11,516,000 | |
| -9,918,000 | |
| -13,779,000 | |
| -16,556,000 | |
| -13,021,000 | |
| -11,726,000 | |
| -11,694,000 | |
| -10,983,000 | |
| -11,524,000 | |
| -7,765,000 | |
| -6,635,000 | |
| -7,524,000 | |
| -6,021,000 |